Durand M., Jain M., Robinson B., Aronowitz E., El Douahy Y., Leung R., Scherr D. S., Ng A., Donzeau D., Amiel J., Spincemaille P., Villers A., Ballon D.   HIGH-RESOLUTION MAGNETIC RESONANCE IMAGING DIFFERENTIATES BETWEEN NORMAL HISTOMORPHOLOGICAL SIGNATURES AND PROSTATE CANCER IN THE RESECTED PROSTATE GLAND.  J. Urol..  2016 ;195 :E159-E160
Delpy J. P., Pagès P. B., Mordant P., Falcoz P. E., Thomas P., Le Pimpec-Barthes F., Dahan M., Bernard A.   Surgical management of spontaneous pneumothorax: are there any prognostic factors influencing postoperative complications?.  Eur. J. Cardio-Thorac. Surg..  2016 ;49 :862-867
de Boysson H., Liozon E., Lambert M., Parienti J. J., Artigues N., Geffray L., Boutemy J., Ollivier Y., Maigné G., Ly K., Huglo D., Hachulla E., Hatron P. Y., Aouba A., Manrique A., Bienvenu B.   F-18-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: A multicenter cohort of 130 patients.  Medicine (Baltimore).  2016 ;95
Dalle S., Mortier L., Dutriaux C., Dalac S., Leccia M., Saiag P., Dreno B., Kowal A., Allayous C., Lebbe C.   MelBase, a French national cohort dedicated to melanoma unresectable stage III and IV patients.  J. Invest. Dermatol..  2016 ;136 :S246-S246
Costa S., Byrne M., Pissaloux D., Haddad V., Paindavoine S., Thomas L., Aubin F., Lesimple T., Grange F., Bonniaud B., Mortier L., Mateus C., Dreno B., Balme B., Vergier B., de la Fouchardiere A.   Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.  Am. J. Surg. Pathol..  2016 ;40 :368-377
Cordoba A., Escande A., Lopez S., Mortier L., Mirabel X., Coche-Déqueant B., Lartigau E.   Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients).  Radiat. Oncol..  2016 ;11
Cordoba A., Escande A., Lopez S., Mortier L., Mirabel X., Coche-Déqueant B., Lartigau E.   Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients) (vol 11, 96, 2016).  Radiat. Oncol..  2016 ;11
Corazao-Rozas P., Guerreschi P., André F., Gabert P. E., Lancel S., Dekiouk S., Fontaine D., Tardivel M., Savina A., Quesnel B., Mortier L., Marchetti P., Kluza J.   Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors.  Oncotarget.  2016 ;7 :39473-39485
Copin M. C., Lesaffre M., Berbon M., Doublet L., Leroy C., Tresch E., Porte H., Vicogne J., B. Cortot A, Dansin E., Tulasne D.   High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble form.  Lung Cancer.  2016 ;101 :59-67
Lavogiez C., Mortier L., Mordon S.   Antimicrobial photodynamic therapy in dermatology. Part II: Viral and parasitic infections; perspectives.  Ann. Dermatol. Venereol..  2016 ;143 :62-69